Prolonged B-cell depletion in MuSK myasthenia gravis following rituximab treatment.
Repository Usage Stats
SubjectAntibodies, Monoclonal, Murine-Derived
Fatty Acids, Monounsaturated
Immunologic Deficiency Syndromes
Published Version (Please cite this version)10.1002/mus.24063
Publication InfoYi, John S; Decroos, Emily C; Sanders, Donald B; Weinhold, Kent J; & Guptill, Jeffrey T (2013). Prolonged B-cell depletion in MuSK myasthenia gravis following rituximab treatment. Muscle Nerve, 48(6). pp. 992-993. 10.1002/mus.24063. Retrieved from https://hdl.handle.net/10161/10207.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
More InfoShow full item record
Associate Professor of Neurology
Professor of Neurology
Research Interests: 1. Therapy of neuromuscular disease - immunologic and neuromuscular facilitating agents for myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS). 2. Clinical trials in nerve, muscle and neuromuscular diseases
Alphabetical list of authors with Scholars@Duke profiles.